The drain is slow but real. Metformin blocks B12 uptake in the gut, and your liver stores three to five years' worth, so the tank runs low only after long use. Over four years, mean B12 fell about a fifth, and 7 percentage points more patients dropped below the deficiency cutoff 1. Over 13 years, borderline-low B12 reached about 1 in 5 metformin users 2. Risk climbs with dose and time: each gram of daily metformin roughly triples the odds 3.
The window closes. Caught inside the first year, the tingling and fatigue reverse with a pill. Left longer, the nerve damage in the spinal cord stops fully coming back 4. By the time anyone thinks to check, the fixable stage is usually gone — and gabapentin gets prescribed for what was a vitamin shortage all along.
The whole fix is one line on a lab order.
Some people should start sooner. Vegetarians and vegans begin with less in the tank. Daily acid blockers (omeprazole and the like) strip out the stomach acid B12 needs, the highest-risk common combination. Anyone over 65, or past bariatric surgery, absorbs less to begin with. And off-label users taking it for PCOS, weight, or longevity sit in the same window as the trials but rarely get monitored at all.
Catch it and the next decade looks different. If you're fine, you've spent fifteen dollars and one blood draw. If you're borderline, the pill brings the number back into range within eight weeks 6, and early symptoms (the slow morning brain, the tingling feet) reverse over weeks to months. The bigger win is what doesn't happen: the neuropathy that comes for most long-term diabetics arrives later and lighter because you didn't stack a vitamin shortage on top of it.
The fine print — when to skip it, and what people get wrong
"My B12 came back normal." The low end of normal (200–300 pg/mL) already hides a functional shortage that only MMA catches 5. And deficiency doesn't need anemia first: folate from fortified flour masks the blood changes while the nerves keep taking damage.
The usual miss: foot tingling gets logged as "diabetic neuropathy," gabapentin closes the case, B12 is never checked 4. The quieter miss: tested once at year two, never rechecked, so the year-five deficiency goes uncaught.
- 1de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, Verburg J, Donker AJM, Stehouwer CDA (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. link
- 2Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP (2016). Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology and Metabolism. link
- 3Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM (2006). Risk factors of vitamin B(12) deficiency in patients receiving metformin. Archives of Internal Medicine. link
- 4Wile DJ, Toth C (2010). Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. link
- 5Out M, Kooy A, Lehert P, Schalkwijk CA, Stehouwer CDA (2018). Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial. Journal of Diabetes and its Complications. link
- 6Mahajan R, Gupta K (2010). Revisiting metformin: annual vitamin B12 supplementation may become mandatory with long-term metformin use. Journal of Young Pharmacists. link
დაკავშირებული სახელმძღვანელოში (6)
- — This is the mechanism: metformin drains B12 over years, which is why diabetics on it need the level checked.
- — The B12 metformin drains also feeds the inner ear; the depletion can show up as faster hearing loss.
- — Metformin is a classic driver of the functional B12 gap these extra tests are built to catch.
- — Large red cells in someone on metformin point straight at B12 depletion.
- — Metformin is a common PCOS treatment, and years on it quietly drain B12 — worth checking the level periodically.
- — Metformin is usually the first drug here — and it quietly drains B12 over years, so the level needs checking.
Metformin and B12 Depletion
Annual serum B12 assay (~$25–50, usually insurance-covered for diabetic patients), MMA when borderline (~$50–100), and oral cyanocobalamin 1,000 µg/day at supplement-aisle prices (~$10–20/year). Total under $100/year.
One annual blood draw added to existing diabetes labs; one daily pill if supplementing. Essentially zero ongoing willpower load — sits inside the routine the patient already keeps for diabetes management.
Placebo-controlled RCT (HOME, 4.3 years, 19% B12 drop, NNH ~14 for deficiency) and 13-year DPPOS cohort establish the depletion. Mechanism reproduced in vivo (calcium-dependent ileal interference). Monitoring is guideline-backed by ADA 2024 and NICE NG28.
In the subset who become deficient (~7% biochemically over 4 years per HOME RCT, ~7% at 13 years per DPPOS), repletion reverses paresthesias, fatigue, and early sensory neuropathy within weeks. Real effect for those affected; selective at population level since most metformin users are not yet deficient.
Fatigue is a primary symptom of B12 deficiency; correction restores energy in the deficient subset. The HOME and DPPOS data establish how common the deficient state becomes with chronic metformin use; uncorrected, the energy hit is real but slow-onset and easily attributed to age or diabetes.
Cognitive dulling and slowed processing are recognised B12 deficiency features that reverse with repletion if caught early. Observational data link metformin-associated low B12 to impaired cognitive performance in older adults; effect size is modest and partly confounded by diabetes itself.
B12 deficiency contributes to falls (via sensory ataxia), cognitive decline, and possibly cardiovascular risk via homocysteine elevation in the elderly. Effect on all-cause mortality is small and indirect; the gain here is preventing a contributor, not a major mortality lever.
B12 deficiency is associated with depressive symptoms; correction modestly improves mood in deficient patients. The signal is small and the population effect modest since only a subset reach clinical deficiency.